biology

Manteia Predictive Medicine

Manteia Predictive Medicine is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Manteia Predictive Medicine rather than just read about it. In short: Manteia Predictive Medicine S.A. (initially incorporated under the name "GenInEx S.A.") was a start-up company created in November 2000 as a spin-off of Serono, a Swiss-based biotechnology company, now part of Merck-Serono, by private founders.

Key takeaways

Manteia Predictive Medicine belongs to biology; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Manteia Predictive Medicine to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Manteia Predictive Medicine from memory before moving on to harder problems.

Reference excerpt

Manteia Predictive Medicine S.A. (initially incorporated under the name "GenInEx S.A.") was a start-up company created in November 2000 as a spin-off of Serono, a Swiss-based biotechnology company, now part of Merck-Serono, by private founders. Its aim was to provide preventive and curative treatment guidelines for common and complex diseases. These guidelines were envisaged as composed of two parts:

a "personal genome card" containing the entire genome sequence of the person holding the card an Internet link to a treatment database to be referenced by doctors The company was basing its strategy on the development of so-called "DNA colony sequencing" technology (now commercialized by Illumina), its proprietary massive parallel sequencing technology whose development had been initiated in late 1996 at Glaxo-Welcome's Geneva Biomedical Research Institute (GBRI), by Pascal Mayer and Laurent Farinelli. This work has been protected by several patents and patents applications, publications and was discussed in presentations at international conferences from 1998 to 2001. By the end of 2003, while the company was progressing along its plans towards realizing an industrial instrument capable of sequencing a complete human genome in approximately 24 hours, strategic considerations led the main shareholder (Serono) to sell Manteia's colony DNA sequencing technology to UK based Solexa Ltd, now part of Illumina (company).

Worked examples

Example 1 — a first encounter with Manteia Predictive Medicine

Start with the simplest possible case. Write down what Manteia Predictive Medicine claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Manteia Predictive Medicine before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Manteia Predictive Medicine ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Manteia Predictive Medicine

In research: Manteia Predictive Medicine appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Manteia Predictive Medicine in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Manteia Predictive Medicine is common in secondary-school and first-year university syllabi. It links to neighbouring topics 2000 establishments in Switzerland, Biotechnology companies established in 2000, Biotechnology companies of Switzerland, so understanding it makes those chapters shorter.
In everyday life: Look for Manteia Predictive Medicine outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Manteia Predictive Medicine” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Manteia Predictive Medicine in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Manteia Predictive Medicine means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Manteia Predictive Medicine out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Manteia Predictive Medicine in simple terms?

Why does Manteia Predictive Medicine matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Manteia Predictive Medicine?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Manteia Predictive Medicine.